Cten signals through integrin-linked kinase (ILK) and may promote metastasis in colorectal cancer

CTEN/TNS4 is an oncogene in colorectal cancer (CRC), which can induce cell motility although its mechanistic basis of activity and the clinical implications of Cten expression are unknown. As Cten is in complex with integrins at focal adhesions, we hypothesised that it may interact with integrin-lin...

Full description

Saved in:
Bibliographic Details
Published inOncogene Vol. 30; no. 26; pp. 2997 - 3002
Main Authors Albasri, A, Al-Ghamdi, S, Fadhil, W, Aleskandarany, M, Liao, Y-C, Jackson, D, Lobo, D N, Lo, S H, Kumari, R, Durrant, L, Watson, S, Kindle, K B, Ilyas, M
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 30.06.2011
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:CTEN/TNS4 is an oncogene in colorectal cancer (CRC), which can induce cell motility although its mechanistic basis of activity and the clinical implications of Cten expression are unknown. As Cten is in complex with integrins at focal adhesions, we hypothesised that it may interact with integrin-linked kinase (ILK). Through forced expression and knockdown of Cten in HCT116 and SW620 (respectively, showing low and high Cten expression), we showed that Cten could regulate ILK. However, inhibition of ILK after forced expression of Cten abrogated the motility-inducing effects of Cten, thereby demonstrating that the Cten–ILK interaction was functionally relevant. Combined knockdown of Cten and ILK had no additive effects on cell motility compared with knockdown of each individually. In order to investigate the clinical implications of Cten expression, a series of 462 CRCs were evaluated by immunohistochemistry. High expression of Cten was associated with advanced Dukes’ stage ( P <0.001), poor prognosis ( P <0.001) and distant metastasis ( P =0.008). The role of Cten in metastasis was tested by (a) intrasplenic injection of CRC cells stably transfected with a Cten expression vector into nude mice and (b) testing a series of primary human CRCs and their metastases by immunohistochemistry. Compared with controls, mice injected with cells expressing Cten developed larger tumours in the spleen ( P <0.05) and liver ( P <0.05). In the human cases, compared with primary tumours, the metastatic deposits had a significantly higher frequency of nuclear localisation of Cten ( P =0.002). We conclude that Cten expression is of prognostic significance in CRC, and we delineate a Cten–ILK pathway controlling cell motility and possibly promoting metastasis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0950-9232
1476-5594
DOI:10.1038/onc.2011.26